5/19/2014

Carroll Community College

NURS 140
Medication Table

Medication Name
generic name
trade name
Classification

Route
Usual Dose
Most common side
effects
Nursing Assessments *Patient dose
*Frequency



*Why med is
ordered for this
patient:
Generic:
Acetaminophen
Trade: Tylenol

Classification:
Antipyretics, Nonopioid
Analgesics




PO 325-650
MG Q4-6HR

IV 1000 MG
Q6H OR 650
MG Q4H

RECT 325-650
MG Q4-6HR
ANIEXTY
DYSPNEA
HYPO/HYPERTENSIVE
RENAL FAILURE
MUSCLE SPAMS
HEPATOTOXICITY
*Overall health status and
alcohol usage before
administration.
*For pain: assess type,
location, and intensity prior
to and 30-60 min following
administration
*For fever: assess fever,
note presence signs
*Monitor labs: LDH, AST,
ALT and PTINR
*Assess for toxicity or
overdose

650 MG PO Q6H
PRN (Temp > 38.5)

On admission,
patient presented
with a fever.
Generic: Atorvastatin
Calcium
Trade: Lipitor

Classification: Lipid-
lowering agents, HMG-
CoA reductase inhibitor


(lowers total and LDL
clolesterol and
trigylcerides)



PO 10-20 MG
ONCE DAILY
INITITALLY,
MAY
INCREASE
Q2-4 WEEKS
UP TO 80
MG/DAY
ABD CRAMPING
CONSTIPATION
FLATUS
HEARTBURN
RASHES
RHABDOMYOLYSIS
*Obtain a dietary history
(fat consumption)
*Monitor labs: LFT
*Assess for toxicity or
overdose-muscle
tenderness, check CK
levels
40 MG PO QPM
Generic: Bisacodyl
Trade: Dulcolax

Classification: Laxative
PO 5-15
MG/DAY AS A
SINGLE DOSE

ABD CRAMPING
NAUSEA
*Assess abdomen-
presence and pattern of
bowel sounds or function
*Assess stool-color,
10 MG RC QDAY
PRN
(UNABLE TO TAKE
PO)
Abdominal
ultrasound showed
the presence of
gallstone which

5/19/2014

(stimulates peristalsis-
evacuation of the colon)




RECT 10
MG/DAY
SINGLE DOSE
consistency, and amount could cause
constipation

Generic: Carvedilol
Trade: Coreg

Classification:
Antihypertensive, beta
blocker

(Helps decrease heart
rate and blood pressure,
improves cardiac output,
slows progression of
HF)




PO:
For
hypertension-
6.25 MG BID
DAILY

For HF- 3.125
MG BID DAILY

For MI- 6.25
MG BID DAILY


(dose may be
increase)

DIZZINESS
FATIGUE
WEAKNESS
DIARRHEA
ERECTILE
DYSFUNCTION
HYERGLYCEMIA
*Monitor BP and pulse
*Monitor I/O
*Monitor labs: BUN, Lipids,
K, Triglyceride, uric acid
*Assess for toxicity or
overdose-bradycardia,
SOB, dizziness, seizures
9.375 MG PO BID Patient has a history
of HTN and MI
Generic: Dronedarone
Hydrochloride
Trade: Multaq

Classification:
Antiarrythmic,
bensofurans

(Suppression of
AF/AFL)






PO 400 MG
BID DAILY
WEAKNESS
ABD PAIN
DIARRHEA
VOMITING
HF
HEPATOTOXICITY
*Assess S/S of AF
*Monitor EKG
*Monitor Labs: hepatic
enzyme, K, Mag,
Creatinine
*Assess for toxicity or
overdose-S/S of hepatic
injury
400 MG PO BID Patient has a history
of dysrhythmia
Generic:
Diphenhydramine HCL
Trade: Benadryl
PO
For allergy:
25-50 MG Q4-
DROWINESS
ANOREXIA
DRY MOUTH
*Determine purpose of
medication
*Assess for patency of
25 MG PO Q6H PRN Patient has a history
of allergies:
-seafood

5/19/2014

Classification: Allergy,
cold, and cough
remedies,
antihistamines,
antitussive

(decreases the
symptoms of histamine
excess and suppress
cough)


6HR

For cough:
25 MG Q4H
PRN

IV (IM)
25-50 MG Q4H
PRN

TOPICAL
APPY TO
AFFECT ARE
UP TO 3-4
TIMES DAILY
airway
*Assess for degree allergy
S/S, cough, and pruritus
*Assess movement
disorder
*Assess sleep patterns
*Assess motion sickness
*Monitor lab: may
decrease skin reaction to
allergy testing
-chocolate
-pineapple
-verapamil (HTN
med)
Generic: Gabapentin
Trade: Neurontin

Classification: analgesic
adjuncts,
anticonvulsants, mood
stabilizer

(decreases incidence of
seizures, post herpetic
pain, leg restlessness)

PO
For
neuropathic
pain:
100 MG TID
DAILY
INITIALLY.
TITRATE
WEEKLY BY
300 MG/DAY-
MAX DOSE
3600 MG/DAY
CONFUSION
DEPRESSION
DROWINESS
ATAXIA
SUCIDAL THOUGHTS

MUTIL-ORGAN
HYPERSENSITIVELY
REACTIONS
*Monitor behavior changes
*For neuropathic pain:
assess location,
characteristics, and
intensity of pain
*Monitor lab: could cause
false reading of urinary
protein
100 MG PO TID Use to treat
patients
neuropathic pain.
Patient is schedule
for bone scan today
for further studies
Generic: Hydromorphine
HCL
Trade: Diaudid

Classification: Opioid
agonist

(Decrease in moderate
to serve pain)





PO
4-8 MG Q3-4H
INITIALLY

IV,IM,SUBCUT
0.015 MG/KG
Q3-4 HR PRN
INTIALLY
RESP. DEPRESSION
CONFUSION
SEDATION
HYPOTENSION
CONSTIPATION
*Assess BP, pulse, and
resp. (before, periodically,
and after administration)
*Asses bowel function
*Assess pain
*Monitor lab: may increase
plasma amylase and lipase
*Assess for toxicity or
overdose-resp. depression
to coma
0.5 MG IV Q3H PRN
(MODERATE PAIN
4-6 IF PT IS NPO
OR PAIN IS NOT
CONTROLLED BY
ORAL
MEDICATION)
Patient complains of
lower side back pain
Generic: PO DIZZINESS *Assess for sulfa 12.5 MG PO QDAY Patient has a history

5/19/2014
Hydroclorothiazide
Trade:Urozide

Classification:
Antihypertensive,
diuretic

(Lowers BP and diuresis
with mobilization of
edema)

12.5-100
MG/DAILY IN
1-2 DIVIDED
DOSES
MUSCLE CRAPMS
HYPOKALEMIA
SJS

SULFA ALLERGIES!!!
allergies
*Monitor BP
(before/periodically), I/O,
daily weights
*Assess neuro and
musculoskeletal
*Monitor K, BS, BUN,
CREAT, and URIC ACID


of HTN and bladder
problems
Generic: Lorazepam
Trade: Ativan

Classification:
antianxiety,
sedative/hypnotic

(sedation and
decreases
anxiety/seizures)

PO
1-3 MG 2-3X
DAILY

SL
2-3 MG/DAY
IN DIVIDED
DOSES, NOT
EXCEED 6
MG/DAY

IM
50MCG 2HR
BEFORE
SURGERY

IV
44MCG 15-
20MINS
BEFORE
SURGERY
DIZZINESS
DROWINESS
LETHARGY

IV RAPID USE:
APNEA
CARDAIC ARRESS
*Geri-assess for CNS
reactions (risk for falls)
*For anxiety- assess
degree and manifestation
of anxiety and mental
status
*Monitor labs: renal,
hepatic, hem function
*Assess for toxicity or
overdose-
FLUMAZENIL=ANTIDOTE
(do not use with seizure)
0.5 MG PO Q8H
PRN
Patient is
claustrophobic and
got a little anxious
prior to MRI scan.
Patient was treated
with anxiety
medication and test
was change to a
bone scan instead.
Generic: Lidocaine HCL
5%
Trade: KCL, K-Dur

Classification:
Supplement
APPLY TO
AFFECTED AREA
TP UD PRN

Generic: Magnesium
Hydrox (Lax)
Trade: KCL, K-Dur

30 ML PO Q12H
PRN


5/19/2014
Classification:
Supplement




Generic: Ondansetron
HCL
Trade: KCL, K-Dur

Classification:
Supplement



4 MG IV Q6H PRN
Generic: Potassium
Chloride
Trade: KCL, K-Dur

Classification:
Supplement
20 MEG PO BID
Generic: Promethazine
HCL
Trade: KCL, K-Dur

Classification:
Supplement
25 MG PO TID PRN
Generic: Vancomycin
HCL/D5W
Trade: KCL, K-Dur

Classification:
Supplement
1250 MG IV
(150ML/HR INFUSE
OVER 120 MINS-
1600/0400)

Generic: Warfarin
Trade: KCL, K-Dur

Classification:
Supplement
DOSINF AS PER
PHARMACY
TODAY INR 1.9
5MG PO AT 1800
(2/24)

Generic: Ondansetron
HCL
Trade: KCL, K-Dur



5/19/2014
Classification:
Supplement